This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revision | ||
bacteria:t3e:xopo [2020/07/03 14:26] – rkoebnik | bacteria:t3e:xopo [2025/02/13 15:30] (current) – [The Type III Effector XopO from //Xanthomonas//] rkoebnik | ||
---|---|---|---|
Line 1: | Line 1: | ||
- | ====== XopO ====== | + | ====== |
Author: Harrold van den Burg\\ | Author: Harrold van den Burg\\ | ||
Internal reviewer: [[https:// | Internal reviewer: [[https:// | ||
- | Expert reviewer: | + | Expert reviewer: |
Class: XopO\\ | Class: XopO\\ | ||
Family: XopO\\ | Family: XopO\\ | ||
- | Prototype: XopO (// | + | Prototype: XopO (// |
- | RefSeq | + | GenBank |
+ | RefSeq ID: [[https:// | ||
3D structure: Unknown | 3D structure: Unknown | ||
Line 15: | Line 16: | ||
=== How discovered? === | === How discovered? === | ||
- | XopO was discovered by a random transponson insertion (Tn//5//) screen using a AvrBs2< | + | XopO was identified in a genetic screen, using a Tn//5//-based transposon construct harboring the coding sequence for the HR-inducing domain of AvrBs2, but devoid of the effectors' |
=== (Experimental) evidence for being a T3E === | === (Experimental) evidence for being a T3E === | ||
- | XopO fused to the Cya reporter | + | Type III-dependent secretion |
=== Regulation === | === Regulation === | ||
Line 24: | Line 25: | ||
=== Phenotypes === | === Phenotypes === | ||
- | * Roden et al. did not find significant growth defects of a // | + | * Roden et al. did not find significant growth defects of a //Xcv// Δ//xopO// mutant in susceptible pepper and tomato leaves (Roden et al., 2004). |
- | * XopO from // | + | * XopO from //Xcv// 85-10 inhibits cell death in //N. benthamiana// |
* XopO suppresses //X. euvesicatoria-// | * XopO suppresses //X. euvesicatoria-// | ||
- | * XopO failed to inhibit expression of the reporter gene // | + | * XopO failed to inhibit expression of the reporter gene //FRK1// in response to application of a PAMP, i.e. flg22 peptide (Popov //et al//., 2016). |
- | * Based on whole genome sequences of //X. euvesicatoria// | + | * Based on whole genome sequences of //X. euvesicatoria// |
=== Localization === | === Localization === | ||
Line 40: | Line 41: | ||
=== Interaction partners === | === Interaction partners === | ||
- | XopO was shown to interact with tomato 14-3-3- proteins | + | XopO was shown to interact with tomato 14-3-3 (TFT) proteins |
===== Conservation ===== | ===== Conservation ===== | ||
Line 46: | Line 47: | ||
=== In xanthomonads === | === In xanthomonads === | ||
- | Yes, in some xanthomonads (//e.g.//, //X. euvesicatoria//, | + | Yes, in some xanthomonads (//e.g.//, //X. euvesicatoria//, |
=== In other plant pathogens/ | === In other plant pathogens/ | ||
- | Yes, // | + | Yes, // |
===== References ===== | ===== References ===== | ||
- | Barak JD, Vancheva T, Lefeuvre P, Jones JB, Timilsina S, Minsavage GV, Vallad GE, Koebnik R (2016) Whole-genome sequences of // | + | Barak JD, Vancheva T, Lefeuvre P, Jones JB, Timilsina S, Minsavage GV, Vallad GE, Koebnik R (2016) Whole-genome sequences of // |
- | Dubrow Z, Sunitha S, Kim JG, Aakre CD, Girija AM, Sobol G, Teper D, Chen YC, Ozbaki-Yagan N, Vance H, Sessa G, Mudgett MB (2018). Tomato 14-3-3 proteins are required for // | + | Dubrow Z, Sunitha S, Kim JG, Aakre CD, Girija AM, Sobol G, Teper D, Chen YC, Ozbaki-Yagan N, Vance H, Sessa G, Mudgett MB (2018). Tomato 14-3-3 proteins are required for //Xv3// disease resistance and interact with a subset of // |
Hajri A, Brin C, Zhao S, David P, Feng JX, Koebnik R, Szurek B, Verdier V, Boureau T, Poussier S (2012). Multilocus sequence analysis and type III effector repertoire mining provide new insights into the evolutionary history and virulence of // | Hajri A, Brin C, Zhao S, David P, Feng JX, Koebnik R, Szurek B, Verdier V, Boureau T, Poussier S (2012). Multilocus sequence analysis and type III effector repertoire mining provide new insights into the evolutionary history and virulence of // | ||
- | Koebnik R, Kruger | + | Koebnik R, Krüger |
- | Lang JM, Pérez-Quintero AL, Koebnik R, DuCharme E, Sarra S, Doucoure H, Keita I, Ziegle J, Jacobs JM, Oliva R, Koita O, Szurek B, Verdier V, Leach JE (2019). A pathovar of // | + | Lang JM, Pérez-Quintero AL, Koebnik R, DuCharme E, Sarra S, Doucoure H, Keita I, Ziegle J, Jacobs JM, Oliva R, Koita O, Szurek B, Verdier V, Leach JE (2019). A pathovar of // |
- | Li G, Froehlich JE, Elowsky C, Msanne J, Ostosh AC, Zhang C, Awada T, Alfano JR, (2014). Distinct // | + | Li G, Froehlich JE, Elowsky C, Msanne J, Ostosh AC, Zhang C, Awada T, Alfano JR, (2014). Distinct // |
- | Popov G, Fraiture M, Brunner F, Sessa G (2016). Multiple // | + | Popov G, Fraiture M, Brunner F, Sessa G (2016). Multiple // |
- | Roden JA, Belt B, Ross JB, Tachibana T, Vargas J, Mudgett MB (2004). A genetic screen to isolate type III effectors translocated into pepper cells during // | + | Roden JA, Belt B, Ross JB, Tachibana T, Vargas J, Mudgett MB (2004). A genetic screen to isolate type III effectors translocated into pepper cells during // |
- | Teper D, Sunitha S, Martin GB, Sessa G (2015). Five // | + | Sohn KH, Zhang Y, Jones JD (2009). The // |
+ | |||
+ | Teper D, Sunitha S, Martin GB, Sessa G (2015). Five // | ||
+ | |||
+ | ===== Acknowledgements ===== | ||
+ | |||
+ | This fact sheet is based upon work from COST Action CA16107 EuroXanth, supported by COST (European Cooperation in Science and Technology). | ||